$Novo Nordisk AS(NVO.US) This stock currently has no institutional involvement and can be considered abandoned by capital. Retail investors hold over 80%, surpassing Tesla. Currently, trapped positions account for about 70%-90%, with an average cost of $75-83. The stock price decline is not due to heavy short selling but rather low liquidity combined with quantitative trading, resulting in larger fluctuations. The low-level consolidation is expected to persist for another half a year before the trend changes. Currently, it's experiencing a minor rebound in valuation recovery.